Middle Individual Division

Challenge 1
The future scene states that "The Nanofirst emergency medicine system does have issues, but nowhere near as many as influencers and neg-media make out". This may be a challenge because due to misinformation spread by these social influencers, the public may become untrustworthy of nanotechnology. This may lead to people not using the benefits of nanotechnology, such as for medical purposes, due to the information spread on social media in 2042 and beyond.

Challenge 2
The future scene states that "Xander is an excellent paramedic, but is known for being overly-cautious, so is more hesitant than others to implement Nanofirst in treatment". This may be a challenge because it shows the utilisation of nanotechnology for medicinal purposes is decided by humans, where their different traits, such as being overly-cautious, determines the use of Nanofirst in treatment. This may lead to ethical debates and conflict to arise, questioning whether nanotechnological treatment should truly be decided by a single person.

Challenge 3
The future scene states that "How many jobs may be impacted in the future is unclear". This may be a challenge because it shows that due to the advanced diagnosis nanotechnology, doctors and paramedics do not truly need to use their knowledge and education on health, as the technology can already identify certain treatments. This may lead to a decline in jobs due to nanotechnology taking over most industries.

Challenge 4
The future scene states that "...but as usual his virtual assistant has misunderstood which issues are most important for human health and wellbeing, but it's not the order he could choose". This might be a challenge because it highlights the issues nanotechnology diagnostic technology has of identifying the severity of certain patient scenarios. This may lead to patients with more critical conditions to be prioritised lower than others, causing them to not be treated first therefore lowering their mortality rate.

Challenge 5
The future scene states that "Nanofirst are not designed for long term function". This may be a challenge because this technical issue makes it work ineffectively after long periods of time, needing frequent maintenance and repairs. This may lead to the diagnostics performed by Nanofirst to be ineffective when its functional issues are unidentified in 2042 and beyond.

Challenge 6
The future scene states that "Dr Robbins wonders if it is true incompatibility or just corporations protecting their intellectual property and market share". This may be a challenge because it shows that corporations and companies of nanotechnology are prioritising their own financial profits over ensuring the lives of people are saved. This may lead to a large percentage of patient deaths being caused by this imcompatibility of nanotechnology due to the selfish characteristics of these corporations.

Challenge 7
The future scene states that "Countries in Europe and Asia have been using nanotechn in paramedicine for years, and it's time Australia caught up". This may be a challenge because it outlines how some countries are behind in the utilisation of nanotechnology in their society. This may lead to the economy as well as infrastructure in these societies that do not have access to nanotechnology to fall behind compared to these other countries in 2042 and beyond.


“Low- income countries are at risk of being left behind without access to high-quality research, widening the global gap between rich and poor” - Nanotechnology RRR Page 5

Challenge 8
The future scene states that "Respirocyte nanotech offers the capability of administering oxygen directly to brain and

Underlying Problem
Because the usage of nanotechnology for treatment in Queensland Australia is decided by paramedics like Xander, leading to their own character traits deciding whether Nanofirst should be utilised, How might we implement protective measures to allow patients with critical conditions to still be treated, so that personal bias or hesitation does not compromise urgent medical care ensuring patients recieve equal access to life-saving nanomedical interventions in 2042 and beyond?

Solution 1
Nanotechnology engineers will create CRITICnano. CRITICnano will be nanobots that are deployable from ambulences or drones that immediately detect critical conditions. These nanobots would integrate advanced biosensing technologies—including optical pulse for oxygen saturation and dry-electrode EEGs for neural activity, that can detect any conditions from a patient even from a far distance away. This system is a protective measure allowing patients with critical conditions to still be treated as it immediately detects any unsual or critical activity, alerting not only the user paramedic but also the supervisors, allowing them to be aware of the situation. The CRITInano ensures personal bias or hesitation does not compromise urgent medical care because it swiftly detects any key conditions that are worthy of the utilisation of nano-integrated treatment instead of just letting paramedics alone decide whether the condition is severe enough.

Solution 2
Network creators and coders will create the N4NO-UN1T3. N4NO-UN1T3 will be a wide communication network where all ambulances and hospitals feed live patient data into the network; with the system automatically approving or denying Nanofirst usage at different priority levels in real time, issuing authorisation in seconds. This allows authority over who gets treatment moves from individuals to a transparent, blockchain defended data-driven system, governed by the foundations of ethics and medicinal knowledge. N4NO-UN1T3 is a protective measure allowing patients with critical conditions to be treated as it allows these decisions to be made based off ethical aspects compared to personal judgement. N4NO-UN1T3 ensures patients recieve equal access as it lists the patients by true relevance and severity, allowing patients to be treated rightfully.

Solution 3
Chip engineers will create the NanoFirstConsent. The NanoFirstConsent will be a small biometric implant storing each individual’s pre-consented medical directives. When scanned by emergency responders, it instantly confirms whether the patient has authorised Nanofirst use, removing hesitation or ethical uncertainty. As well as this, the chip will also contain information such as pregnancy as well as information about their toxin levels. NanoFirstConsent is a protective measure allowing patients with critical conditions to still be treated as it reduces the hesitation as well as legal actions in relations to the patient giving consent to the treatment. NanoFirstConsent ensures patients receive equal access to life-saving nanomedical interventions as all chips will be the same, as well as allowing paramedics to identify those who do not want to be correlated with nanofirst treatment for ethical or religious purposes.

Solution 4
Virtual Reality engineers will create the NANOrisks-TEACH. NANOrisks-TEACH will be virtual modules that use fictional information and data on patients where paramedics need to decide whether and what treatment should be given to the patient. NANOrisks-TEACH will not only provide an infinite source of scenarios but additionally, paramedics will need to give reasons for their answers, ensuring that they truly understand the requirements for nano-medicine as such. NANOrisks-TEACH is a protective measure to allow patients with critical conditions to still be treated as it prepares paramedics to immediately highlight specific aspects of a patient to rightfully and ethically decide the decision of utilising nanotechnology. NANOrisks-TEACH ensures patients recieve equal access to life-saving nanomedical interventions as these requirements will never change, unless advised by the government or legal advisors and supervisors, allowing the use of the treatment to be equal to everyone.

Solution 5
Electromagnetic engineers will create the HALT2042. HALT2042 will be a emergency device that will be accessible by both paramedics and doctors that utilises high-power microwaves that can generate focused EM pulses with an intensity capable of disrupting or stopping nanotechnological devices in case of emergencies. HALT2042 will be used specifically for patients that contain a varying company's technology, allowing nanofirst to be implemented to save their lives. It will also identify both consent to use this device, as well as the purpose of the varying company's device, such as for a heart disease, to allow paramedics to know what to apply pressure on whilst saving them with nanofirst treatment. HALT2042 is a protective measure allows patients with critical conditions to be treated as it stops paramedics from directly giving up on patients with these devices implanted as well as reducing hesitation. HALT2042 will ensure equal access as patients would have given consent for this use.

Solution 6
Coders will create the ALGORITHM 2.1. ALGORITHM 2.1 will be a data driven algorithm that contains all information and data of the order patients are treated in and highlighting a few that were prioritised lower due to the code or human decisions. This algorithm will then highlight each similarity between these patients, outlining key conditions that when diagnosed by nanotechnology are not truly sorted by their true relevance and therefore being prioritised lower to doctors. With this information, nanotechnological diagnosis bots will then be updated with this new information. ALGORITHM 2.1 is a protective measure allowing patients with critical conditions to be treated as it ensures towards the future, millions of critical condition people with the same condition are saved rightfully. ALGORITHM 2.1 ensure patients recieve equal access as they have a right not to contribute to ALGORITHM 2.1, as well as ensuring patients will recieve these nanomedical interventions towards the future.

Criterion 1
Which solution will be the best protective measure that allows patients with critical conditions to still be treated?

Criterion 2
Which solution will best allows personal bias to not compromise urgent medical care?

Criterion 3
Because nanomaterials often require advanced fabrication and expensive training processes, which solution will be the most cost-effective?

Criterion 4
Because nanoscale materials can have unpredictable interactions with biological systems, which solution will be the most biocompatible?

Criterion 5
Because social medica affects the trust between the public and nanotechnology, which solution will be the most accepted by the public?

ALoU 1

Solution #:
2

Summary:
N4NO-UN1T3 is a wide communication network where all ambulences and hospitals feed live patient data into the network, the system automatically approving or denying Nanofirst usage at differenct priority levels in real time, which ensures authorisation in seconds

Advantages:
N4NO-UN1T3 allows the decision made from paramedics about the utilisation of nanofirst to be heavily supported and not affected by personal judgement through this network that gives them approval or denial of this use.


Limitations:
Implementation will be an issue as it will take a long period of time to implement worldwide or even just in a region as all paramedics and doctors will need to access this device as well as setting up a viable system centre.

Unique Possibilities:
N4NO-UN1T3 could also be connected to medical devices such as CRITICnano to ensure automatic data input.

ALoU 2

Solution #:
3

Summary:
NanoFirstConsent will be a small biometric implant storing each individual's pre-consented medical directives, that instantly allow paramedics to be aware of their personal rights.

Advantages:
It reduces hesitation by paramedics on whether to perform nanofirst treatment on patients as the chip immediately alerts them of specific details as well as consent.

Limitations:
One limitation may be that the NanoFirstConsent will need frequent updating because it needs to ensure all data about the patient is updated, such as pregnancy or toxin levels.

Unique Possibilities:
Unique possibilities include how the information stored on the NanoFirstConsent could be defended with blockchain privacy defence which reduces the chance of somebody hacking into its system.

Action Plan
To prevent patients with critical conditions to be prioritised lower in relations to being treated by nanofirst or other nanomedicinal technologies, chip engineers will create the NanoFirstConsent. The NanoFirstConsent will be a small biometric implant storing each individual’s pre-consented medical directives. When scanned by emergency responders, it instantly confirms whether the patient has authorised Nanofirst use, removing hesitation or ethical uncertainty. This technology will reduce the hesitation by paramedics on the overall consent and other data on certain patients.

NanoFirstConsent works as paramedics will be equipped with a special scanning device, which when it detects the specific chip of the patient, it immediately alerts them with their status, information on their health, as well as consent. The NanoFirstConsent significantly mitigates the number of patients diseased as it reduces personal judgements of paramedics to affect their decision of using nanomedicinal technologies, as all of the consent as well as data will be on the chip. The NanoFirstConsent will be implemented in a time period closest to a term, as the data on all citizens will need to first be recorded as well as created into a chip, which will then be implemented into their arms.

A supporter of the NanoFirstConsent may be paramedics, as now they will have a reduced hesitation period of time with the addition of NanoFirstConsent, as it provides them with details such as consent and data, which would have contributed to the amount of time "wasted" without this solution. A resistor of the NanoFirstConsent may be people who suffer from financial stress as they are unable to afford for this technology. To allow these people to support the NanoFirstConsent, the World Health Organisation could help fund for these technologies, allowing these people to still access the technology.

However, despite its benefits, the NanoFirstConsent still has limitations. One limitation may be the NanoFirstConsent requires frequent updating because it needs to ensure all the data about the patient is updated and correct, allowing the paramedic's understanding of the patient to be more effective. This obstacle can be overcome with immediate updating, as the NanoFirstConsent could be equipped with a sensor that immediately updates health-related data like blood level toxins.

The NanoFirstConsent works as the best protective measure for patients under critical conditions as it reduces the period of time paramedics waste while hesitating or being influenced under personal judgement, as the data along with the consent will be illustrated. The NanoFirstConsent best allows personal bias not to compromise urgent medical care as it already provides effective data for paramedics about the utilisation of nanofirst. NanoFirstConsent is the most cost-effective because it will not be a profit driven corporation, rather one that focuses on the actual health of citizens. The NanoFirstConsent is the most biocompatible because it will be created using recycled materials for its outer protective shell. The NanoFirstConsent will be the most accepted by the public as it allows their personal rights to be illustrated through this chip, allowing paramedics to be alerted if they do not want to be associated with any nanotechnology.

The NanoFirstConsent is humane as it does not have any negative effects other than containing personal health data of the user. This data however will be put in a blockchain defended system that prevents any hacking to occur. The NanoFirstConsent will have a positive impact on the future scene as it prevents patients presented in the story to be diseased due to personal judgement like Xander or Ella to contribute to the decision of using nanofirst. The NanoFirstConsent will have a positive impact on the underlying problem as it allows patients with critical conditions to be treated due to the chip prioritising patients rightfully by relevance, allowing their condition to still be treated before too severe.